Table 1.
Specimen | NFs | TAFs | TCFs | Tumor size (cm) | Differentiation status | Prior Treatment | Comorbordities | Smoker status | Common mutations | Classification | Node status | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | X | X | X | 3.5 | Well | None | None | Never | EGFR exon 19 deletion | Acinar 85%, lepidic 10%, pipillary 5% | N0 | ||||||||||||||||||
2 | X | X | X | 2.6 | Moderate | None | Hypertension | Former | None | Papillary 50%, acinary 30%, lepidic 20% | N1 | ||||||||||||||||||
3 | X | X | X | 3.5 | Moderate | None | Hypertension | Never | None | Acinar 70%, papillary 25%, lepidic 5% | N1 | ||||||||||||||||||
Specimen | Sex | Stage | Tumor size (cm) | Differentiation status | Prior Treatment | Comorbordities | Smoker status | Common mutations | Classification | Node status | |||||||||||||||||||
59 | F | 2 | 2.1 | Unknown | None | Hypercholesterolemia, hypertension, disc rupture L4-L5 | Never | Unknown | Invasive adenocarcinoma, papillary predominant | N0 | |||||||||||||||||||
Number of patients | Grade | Histology | Stage | Cancer cell/Stroma compartmentalization | |||||||||||||||||||||||||
Poor | Moderate | Well | Unknown | Adeno | Broncho-alveolar | Mixed adeno/broncho-alveolar | 1 | 2 | 3 | 4 | Y | N | |||||||||||||||||
160 | 54 | 138 | 53 | 15 | 217 | 32 | 11 | 146 | 70 | 43 | 1 | 30 | 230 |